Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion type Assertion NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_head.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion description "[To identify a gp100 epitope restricted by the MHC class II allele with the highest prevalence in patients with malignant melanoma (HLA-DRB1*0401), we immunized mice transgenic for a chimeric human-mouse class II molecule (DR4-IE) with recombinant human gp100 protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_provenance.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion evidence source_evidence_literature NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_provenance.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion SIO_000772 10725708 NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_provenance.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion wasDerivedFrom befree-2016 NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_provenance.
- NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_assertion wasGeneratedBy ECO_0000203 NP278495.RAiZeT_HdBUWiENtQbOe-IPvspCkhg6Uc9c4tiRmXUZLc130_provenance.